Vitamin D 1000 IU vs 5000 IU

The two reference points

The Institute of Medicine published the current dietary reference intakes for vitamin D in 2010, and they haven't been revised. The Recommended Dietary Allowance is 600 IU (15 mcg) a day for adults from 19 through 70, and 800 IU (20 mcg) a day from 71 on. That figure carries an assumption worth knowing. It was set for people getting minimal sun exposure, so it's meant to cover winter, indoor work, and high latitudes in one number. It was also set against a single outcome, bone health, because that was the outcome with enough trial data behind it.

The tolerable upper intake level for everyone nine and older is 4,000 IU (100 mcg) a day. It covers vitamin D from food and supplements together. It doesn't apply to vitamin D made in skin, since the body limits its own production.

Units cause more confusion than they should.

One microgram equals 40 IU, so a 1,000 IU dose is 25 mcg and a 5,000 IU dose is 125 mcg. Labels increasingly list micrograms, which means a bottle reading 25 mcg and another reading 1,000 IU hold the same amount.

Where 1,000 IU sits

A 1,000 IU daily dose is roughly 1.7 times the RDA for a younger adult and about 1.25 times the RDA for someone over 70. It's a quarter of the tolerable upper intake level. That's inside the range the guidelines describe, and the largest trial tested above it. VITAL gave 2,000 IU a day, twice this amount, to 25,871 adults for a median of 5.3 years.

Where 5,000 IU sits

A 5,000 IU daily dose runs 1,000 IU above the tolerable upper intake level. It's roughly 8.3 times the RDA for a younger adult. Placement matters here. Sitting above the upper level doesn't make a dose toxic. It means the committee that set the level judged the evidence for safety at habitual intakes above that point too thin to call it reassuring. The upper level also doesn't cover a supervised course for a confirmed low blood level, where much higher amounts over a few weeks are standard and are monitored with repeat testing.

The upper level is not the toxicity line

This is the distinction most coverage blurs, so it's worth stating plainly.

The Institute of Medicine described the upper level as the point above which the potential for adverse effects may increase with chronic use, and it said explicitly that the number isn't a target. In the same review, the committee flagged uncertainty about intakes above 4,000 IU a day and about blood 25(OH)D above 75 nmol/L, and noted that levels above 125 nmol/L may raise mortality risk.

The Endocrine Society drew a different line. Its guideline concluded that intakes up to 10,000 IU a day weren't associated with significant alteration of calcium metabolism, and that toxicity is usually seen once blood 25(OH)D exceeds 375 nmol/L.

Both positions are published, and they disagree about where the safety margin ends. That's a real disagreement between expert bodies rather than a settled figure.

Vitamin D toxicity runs through calcium. Early signs include nausea, vomiting, weakness, and frequent urination. Sustained high calcium can damage the kidneys and calcify soft tissue.

The missing long-term data

The trial record covers some doses well and others barely at all.

VITAL used 2,000 IU a day in 25,871 adults for a median of 5.3 years. It found no significant reduction in invasive cancer, with a hazard ratio of 0.96, or in major cardiovascular events, at 0.97. Fractures came in at 0.98 overall. Participants weren't selected for low vitamin D or low bone mass. The D2d trial used 4,000 IU a day in 2,423 adults with prediabetes for a median of 2.5 years. New diabetes occurred in 293 of 1,211 taking vitamin D and 323 of 1,212 taking placebo, a hazard ratio of 0.88 with a confidence interval from 0.75 to 1.04. That interval crosses 1.0, so it isn't a positive result. Nothing comparable exists at 5,000 IU a day across years.

The trials that used high doses used them intermittently, and one of those backfired. A trial published in JAMA in 2010 gave 500,000 IU once a year to older women and found more falls and more fractures in the treated group.

Dosing pattern matters too. Large infrequent doses push 25(OH)D up sharply and then let it fall, and the spike may increase bone resorption. Daily dosing avoids the spike, which argues for steady intake and against correcting a low level with one huge dose outside supervision.

Frequently asked questions

Is 5,000 IU a day dangerous?

There's no trial evidence of harm in the short term, and documented toxicity cases generally involve sustained amounts well above that. Nobody has run a long-term trial at this dose in a general population, so the question stays open.

Why is the upper level 4,000 IU if toxicity starts higher?

Because the two numbers answer different questions. The upper level asks where the evidence for safety runs out. The toxicity threshold asks where harm appears. Committees set upper levels conservatively, below the point where problems show up.

Do I need more than the RDA?

That depends on your blood level, your latitude, your skin, your medications, and your kidneys. The Institute of Medicine named specific groups, including older adults, people with darker skin, and people with fat malabsorption.

Does a higher dose raise the blood marker more?

Yes, in the near term. The trials show a clear dose response in 25(OH)D over weeks. That's a change in a marker, and the trials at higher amounts haven't shown it carries through to better outcomes.

---

This article is for general information only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Talk with your health care provider before using vitamin D at doses above the recommended intake, especially if you take medication or have a kidney condition.

Sources

• NIH Office of Dietary Supplements. Vitamin D Fact Sheet for Health Professionals.
• Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58.
• Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33-44.
• LeBoff MS, Chou SH, Ratliff KA, et al. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med. 2022;387(4):299-309.
• Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381(6):520-530.